IN2014DE00818A - - Google Patents

Download PDF

Info

Publication number
IN2014DE00818A
IN2014DE00818A IN818DE2014A IN2014DE00818A IN 2014DE00818 A IN2014DE00818 A IN 2014DE00818A IN 818DE2014 A IN818DE2014 A IN 818DE2014A IN 2014DE00818 A IN2014DE00818 A IN 2014DE00818A
Authority
IN
India
Prior art keywords
subject
diabetes
borapetoside
metabolite
prodrug
Prior art date
Application number
Other languages
English (en)
Inventor
Ming-Jai Su
Shoei-Sheng Lee
Original Assignee
Orient Europharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orient Europharma Co Ltd filed Critical Orient Europharma Co Ltd
Priority to IN818DE2014 priority Critical patent/IN2014DE00818A/en
Publication of IN2014DE00818A publication Critical patent/IN2014DE00818A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IN818DE2014 2014-03-20 2014-03-20 IN2014DE00818A (ar)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN818DE2014 IN2014DE00818A (ar) 2014-03-20 2014-03-20

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN818DE2014 IN2014DE00818A (ar) 2014-03-20 2014-03-20

Publications (1)

Publication Number Publication Date
IN2014DE00818A true IN2014DE00818A (ar) 2015-09-25

Family

ID=54394329

Family Applications (1)

Application Number Title Priority Date Filing Date
IN818DE2014 IN2014DE00818A (ar) 2014-03-20 2014-03-20

Country Status (1)

Country Link
IN (1) IN2014DE00818A (ar)

Similar Documents

Publication Publication Date Title
MX2023000320A (es) Metodos para modular los niveles de farmaco en plasma mediante el uso de eritrohidroxibupropion.
PH12016500582A1 (en) Heterocyclic compounds and uses thereof
PH12016501809A1 (en) Heterocyclic compounds for use in the treatment of pi3k-gamma mediated disorders
MX2017004471A (es) Compuestos de triazolopiridina y métodos para el tratamiento de fibrosis cística.
MX2018006674A (es) Tratamiento de cancer usando 2-desoxi-2-fluoro-l-fucosa en combinacion con un inhibidor del punto de control.
EP3141603A4 (en) Gpc3-targeted therapeutic agent for administration to patients for whom gpc3-targeted therapeutic agent therapy is effective
PH12017500933A1 (en) Sublingual administration of riluzole
PH12016502352A1 (en) Pharmaceutical composition
TW201613578A (en) Pharmaceutical combinations
PH12017500934A1 (en) Sublingual formulation of riluzole
WO2014160281A3 (en) Method of enhancing delivery of therapeutic compounds to the eye
MX2016016388A (es) Uso de compuestos de tienotriazolodiazepina para el tratamiento de cancer de pulmon de celula no pequeña y/o cancer de pulmon de celula pequeña.
PH12016502233A1 (en) (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine
PH12016502236A1 (en) (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine
MX2021014120A (es) Tratamiento de los sintomas asociados a terapia privacion de androgenos.
MX2016011706A (es) Formulaciones de progesterona.
MX2017014301A (es) Composiciones y metodos para el tratamiento o prevencion de hipertension pulmonar.
IN2014DE00818A (ar)
PH12014000105A1 (en) Therapeutic methods and compositions for treating diabetes utilizing diterpenoid compounds
MX2018006631A (es) Compuesto para uso en la prevencion y tratamiento de enfermedades neurodegenerativas.
IN2014DE00822A (ar)
MX2016013979A (es) Nuevas vias de administracion de insulina, analogos de insulina o derivados de insulina.
MX2016010919A (es) 4-bencilsulfonil-2-butenonitrilo.
PL2852400T3 (pl) Analog insuliny lub jego farmaceutycznie dopuszczalna sól, kompozycja farmaceutyczna o przedłużonym działaniu terapeutycznym, zastosowanie analogu insuliny, sposób dawkowania oraz sposób leczenia cukrzycy